FosB protein levels in laryngeal cancer and outlook
Part of Cancer, Ear, nose & throat, Lungs & breathing clinical trials.
This study looks at a protein called FosB found in laryngeal cancer tissue to see if it can predict how well patients do. By participating, you help doctors understand if this protein can guide treatment decisions and improve outcomes for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with laryngeal cancer (squamous cell carcinoma), confirmed by two pathologists.
- The tumor must be in the larynx (voice box) and must not have spread to distant parts of the body.
- You should be planning to receive standard treatment (like surgery) for the first time at this hospital.
- Your medical records and follow-up information must be complete.
- You must not have other serious or life-threatening diseases, such as a second cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the bacteria and other microbes in lung cancer tissue to understand how they might affect the disease. It may help find new ways to treat or manage non-small cell lung cancer.
This Phase 1 study tests a precise type of radiation treatment for people with certain stages of laryngeal (voice box) squamous cell cancer. The goal is to see how safe the treatment is and how well it may work in shrinking or controlling the cancer while aiming to preserve the larynx.
This trial tests treatment approaches for people with cancers of the voice box (larynx) or lower throat (hypopharynx). It may help by finding which treatment strategy works best for different tumor locations and cancer stages.
This trial tests a new drug, PF-08634404, alone or with other treatments, for people with early-stage or locally advanced non-small cell lung cancer (NSCLC) that can be surgically removed or has been treated with radiation and chemo. It aims to find if the drug helps before or after surgery or after standard treatments.
This study looks at whether changes in your voice can help detect early return of laryngeal or hypopharyngeal cancer. If you’ve finished curative treatment and are disease-free for a certain period, your voice will be monitored to see if it can signal recurrence sooner.
This study looks at virus-related markers and tiny gene regulators (microRNAs) in tumor tissue from people with certain throat cancers caused by human papilloma virus (HPV). It’s observational, meaning it does not change your treatment, but results may help doctors better understand these cancers and how they behave.
Hear when a new Laryngeal Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.